Sorrento Therapeutics, Inc. (SRNE) will report its next earnings on May 14 AMC. The company reported the earnings of $0.18/Share in the last quarter where the estimated EPS by analysts was $-0.14/share. The difference between the expected and actual EPS was $0.32/share, which represents an Earnings surprise of 228.6%.
Many analysts are providing their Estimated Earnings analysis for Sorrento Therapeutics, Inc. and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $-0.17/share. These analysts have also projected a Low Estimate of $-0.17/share and a High Estimate of $-0.16/share.
In case of Revenue Estimates, 2 analysts have provided their consensus Average Revenue Estimates for Sorrento Therapeutics, Inc. as 5.05 Million. According to these analysts, the Low Revenue Estimate for Sorrento Therapeutics, Inc. is 2.5 Million and the High Revenue Estimate is 7.6 Million. The company had Year Ago Sales of 4.87 Million.
Some buy side analysts are also providing their Analysis on Sorrento Therapeutics, Inc., where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Sorrento Therapeutics, Inc. might touch $40 high while the Average Price Target and Low price Target is $25 and $10 respectively.
The Relative Volume of the company is 0.62 and Average Volume (3 months) is 3.92 million.
The company shows its Return on Assets (ROA) value of 2.3%. The Return on Equity (ROE) value stands at 8.2%. While it’s Return on Investment (ROI) value is 27.4%.
While looking at the Stock’s Performance, Sorrento Therapeutics, Inc. currently shows a Weekly Performance of 2.63%, where Monthly Performance is -24.03%, Quarterly performance is 17%, 6 Months performance is 58.11% and yearly performance percentage is 98.31%. Year to Date performance value (YTD perf) value is 53.95%. The Stock currently has a Weekly Volatility of 7.56% and Monthly Volatility of 12.91%.